Effectiveness and Safety Study of Early add-on of Ezetimibe With Atorvastatin in Very High-risk Patients
Condition:   Atherosclerotic Cardiovascular Disease Interventions:   Drug: Atozet 10/40 mg or 10/80 mg;   Drug: Lipitor 40 mg or 80 mg Sponsors:   Organon and Co;   Iqvia Pty Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 9, 2023 Category: Research Source Type: clinical trials

A Clinical Study to Evaluate the Pharmacokinetics of Microdose Midazolam, Dabigatran, Pitavastatin, Atorvastatin and Rosuvastatin in Healthy Volunteers and Renal Impairment Patients
Condition:   Chronic Kidney Disease Intervention:   Drug: Midazolam, dabigatran etexilate, pitavastatin, rosuvastatin and atorvastatin Sponsor:   Peking University Third Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2023 Category: Research Source Type: clinical trials